For The Better

If you’ve seen your investment account balance decline, you may be thinking about claiming Social Security sooner than you originally planned.

Unlike a lot of tech investors, Cathie Wood is super bullish on biotechnology. Here are three of her picks that these Motley Fool contributors love.

These energy stocks can turn $1,000 into a lucrative income stream.

The retailer is making a bold bet on future demand trends.

This Dividend King pays shareholders a market-beating dividend.

Slow and steady growth is an enriching strategy.

A return to exclusively theatrical releases could pay off big for the company.

Losses logged by the company’s streaming services may be on the verge of turning around.

The streaming wars are putting the leading network in a perilous position.

Even as Invitae increases its margins and reduces cash burn, eager traders still might have gotten ahead of themselves.

The video game business is still growing.

Some meme stocks are in the limelight again, but there is plenty of reason for caution.

But inflation and high gas prices are still taking a toll on profits and customer visits.

Investing in biotech stocks without any drugs on the market can be scary. These suggestions can help you make money in this high-risk sector.

After eye-popping growth in 2021, I assumed growth in 2022 would be modest. I was wrong.

50% pullback in shares of cloud-based contact center software provider Five9 presents an opportunity for long term investors.

These companies offer significant payout hikes and long streaks of dividend increases.

Taking too much money out of your retirement accounts too soon could be dangerous.